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The innate and adaptive immune responses that
confer resistance to the intracellular pathogen
Toxoplasma gondii critically depend on IL-12 pro-
duction, which drives interferon-g (IFN-g) expres-
sion. Certain cytokines can activate STAT3 and limit
IL-12 production to prevent infection-associated im-
mune pathology, but T. gondii also directly activates
STAT3 to evade host immunity. We show that sup-
pressor of cytokine signaling molecule 3 (SOCS3),
a target of STAT3 that limits signaling by the
pleiotropic cytokine IL-6, is upregulated in response
to infection but is dispensable for the immune-
inhibitory effects of T. gondii. Unexpectedly, mice
with targeted deletion of SOCS3 in macrophages
and neutrophils have reduced IL-12 responses and
succumb to toxoplasmosis. Anti-IL-6 administration
or IL-12 treatment blocked disease susceptibility,
suggesting that in the absence of SOCS3, macro-
phages are hypersensitive to the anti-inflammatory
properties of IL-6. Thus, SOCS3 has a critical role in
suppressing IL-6 signals and promoting immune
responses to control T. gondii infection.
INTRODUCTION
Toxoplasma gondii is an opportunistic pathogen of patients with
a variety of primary and secondary deficiencies in T cell function
(Denkers and Gazzinelli, 1998). Control of T. gondii is achieved
through a combination of innate and adaptive responses that
are dependent upon accessory cell production of IL-12, which
drives natural killer (NK) and T cells to produce IFN-g (Sher
et al., 2003).These cytokines are critical for long-term resistance
to T. gondii, as mice deficient in either IL-12 or IFN-g succumb to
the acute phase of this infection (Sher et al., 2003). In current
models, the ability of IFN-g to activate the transcription factor
STAT1 synergizes with other factors such as TNF-a, IL-1, and
CD40L that utilize NFkB signaling to promote robust antimicro-
bial responses (Andrade et al., 2005; Lieberman et al., 2004).
Together, these stimuli induce the expression of numerous224 Cell Host & Microbe 10, 224–236, September 15, 2011 ª2011 Elgenes, such as those that code for inducible nitric oxide syn-
thase (iNOS) and the immunity related GTPases (IRGs), that
are critical for resistance to T. gondii (Butcher et al., 2005a;
Martens et al., 2005; Scharton-Kersten et al., 1997).
T.gondii has evolved a number of strategies to evade host anti-
microbial activity and can interfere with NFkB activation (Butcher
et al., 2001; Robben et al., 2004; Shapira et al., 2002) and antag-
onize IFN-g signaling by inhibiting the phosphorylation and
nuclear translocation of STAT1 and also by upregulating Sup-
pressor of Cytokine Signaling Molecule 1, SOCS1, a suppressor
of IFN-g signaling (Dalpke et al., 2008; Kim et al., 2007; Lu¨der
et al., 2001; Zimmermann et al., 2006). This pathogen can also
interferewith recruitment of IRGs to theparasitophorous vacuole,
thus limiting the ability of IFN-g-activated cells to control parasite
replication (Butcher et al., 2005a;Martens et al., 2005; Zhaoet al.,
2009).More recentworkhas revealed thatT .gondii injects a rhop-
try kinase, ROP16, that directly phosphorylates the host tran-
scription factor STAT3, and this event is associatedwith impaired
IL-12p40 and TNF-a production (Butcher et al., 2005b; Saeij
et al., 2007; Yamamoto et al., 2009). Interestingly, STAT3 is also
activated by the cytokines IL-6 and IL-10, which antagonize
antimicrobial effector function and thereby enhance the growth
of the intracellular pathogens T. gondii, Mycobacterium, and
Leishmania (Beaman et al., 1994; Bermudez et al., 1992; Murray,
2008). Together, these observations suggest that the ability of
T. gondii to directly activate STAT3 limits host responses and
promotes parasite survival.
Although STAT3 appears to be a key target of T. gondii, the
downstream effects of STAT3 that promote parasite replication
are unclear. One candidate gene, upregulated by IL-6- and
IL-10-mediated activation of STAT3, is SOCS3, which under
normal circumstances can bind to the gp130 subunit of the
IL-6 receptor complex and limit IL-6 signaling (Kubo et al.,
2003). Because SOCS3 was upregulated in response to
T. gondii, studies were performed using mice in which the
Socs3 gene is flanked by loxP sites and Cre recombinase is ex-
pressed under the control of the Lysozyme M promoter to delete
Socs3 from macrophages and neutrophils (LysM-cre Socs3fl/fl),
to determine its role in the suppressive effects of T. gondii.
Although SOCS3 was not required for the ability of T. gondii to
suppress cytokine production in vitro, infection of these mice re-
sulted in overwhelming parasite burdens characterized by
impaired neutrophil and monocyte responses. Administration
of a-IL-6 or treatment with IL-12 blocked disease susceptibility,sevier Inc.
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SOCS3 and T. gondiisuggesting that in the absence of SOCS3, macrophages are
hypersensitive to the anti-inflammatory properties of IL-6.
RESULTS
Toxoplasma gondii Upregulates SOCS3 in Macrophages
Infection of macrophages with T. gondii in vitro results in the
rapid phosphorylation of STAT3 (Butcher et al., 2005b; Saeij
et al., 2007). Since STAT3 activation is normally associated
with the induction of SOCS3, we used bone marrow-derived
macrophages (BMMf) infected with the Type I strain (RH) or
a Type II strain (Prugniaud) of T. gondii to assess if infection
led to the upregulation of SOCS3. Unstimulated cells had low
basal levels of SOCS3mRNAwith no detectable SOCS3 protein,
while infection with T. gondii induced a rapid increase in mRNA
and protein (Figures 1A and 1B), an effect comparable to that
observed following stimulation with IL-6 (Figure 1A and data
not shown). Similar results were observed using resident perito-
neal macrophages infected with either parasite strain (Fig-
ure S1). Additionally, macrophages stimulated with STAg or
incubated with supernatants from infected cells did not upregu-
late SOCS3 protein, indicating that live parasites are required for
this biological activity (Figure 1B).
To assess if infected cells expressed SOCS3, immunofluores-
cence was performed on BMMf infected for 3 hr with a trans-
genic RH parasite that expresses the fluorescent protein Tomato
(RH-Tomato). To confirm specificity, macrophages deficient in
SOCS3 were used, and SOCS3 protein was not detected by
immunofluorescence in resting macrophages or those isolated
from LysM-cre Socs3fl/fl mice (Figure 1C). Infection resulted in
increased SOCS3 expression in wild-type cells while fluores-
cence was absent in knockout cells. However, these images re-
vealed that in wild-type macrophages, SOCS3 was upregulated
in infected and uninfected cells. Because T. gondii can inject
rhoptry proteins into host cells without directly infecting them
(Koshy et al., 2010), studies were performed to assess whether
this phenomena contributed to the expression of SOCS3 in unin-
fected cells. Therefore, a transgenic RH parasite that expressed
Cre recombinase (RH-Cre-Cherry) was used to infect Socs3fl/fl
BMMf for 3 hr and compared to RH-Tomato. If rhoptry proteins
are involved in the upregulation of SOCS3, then the injection of
the Cre recombinase should excise the Socs3 gene and the
infection-induced upregulation of SOCS3 typically observed in
these cultures should be reduced. Indeed, while RH-Tomato
parasites induced SOCS3 expression, this was markedly re-
duced (by approximately 10-fold, 55% versus 5%) when the
RH-Cre-Cherry parasites were used (Figure 1D). These data
are consistent with a model in which the ability of the parasite
to inject rhoptry proteins into infected and uninfected cells
explains the observed widespread expression of SOCS3.
Since the ability of T. gondii to antagonize IL-12p40 and TNF-a
production from LPS-stimulated macrophages is STAT3-
dependent, experiments were performed to determine if this
effect was also SOCS3-dependent. As previously described
(Butcher et al., 2005b), infection of wild-type BMMf resulted in
a rapid phosphorylation of STAT3 that started to decline by
4 hr and was nearly absent by 24 hr in SOCS3-sufficient macro-
phages infected with T. gondii (Figures 1E and 1F). In SOCS3-
deficient macrophages, STAT3 phosphorylation is enhanced atCell Host & M1 and 4 hr after infection and remains high for up to 24 hr. This
observation is similar to reports that IL-6-mediated activation
of STAT3 is enhanced in the absence of SOCS3 (Yasukawa
et al., 2003) and suggests that the mechanism utilized by
SOCS3 to limit IL-6-activated STAT3 also affects STAT3 phos-
phorylation by T. gondii. To assess whether the presence of
SOCS3 was required for the ability of T. gondii to limit IL-
12p40 production, control or SOCS3-deficient BMMf were in-
fected for 1 hr prior to LPS stimulation and then incubated for
24 hr before cytokine analysis. Stimulation of wild-type macro-
phages with LPS resulted in IL-12p40 secretion, and this was
reduced when SOCS3-deficient macrophages were used
(p < 0.01) (Figure 1G). Infection with T. gondii resulted in a
reduced ability of LPS to induce IL-12p40 and TNF-a in wild-
type and SOCS3-deficient macrophages (Figure 1G and data
not shown). These findings show that infection leads to an upre-
gulation of SOCS3, but this protein is not required for T. gondii to
impair cytokine secretion by macrophages.
LysM-cre Socs3fl/fl Mice Succumb Acutely to T. gondii
Infection
Although SOCS3was not required for T. gondii to suppress cyto-
kine responses in vitro, studieswere performed to assess the role
of this regulatory protein in resistance to T. gondii in vivo. Since
deletion of Socs3 is embryonic lethal, the cre-loxP system was
utilized to generate mice that lack SOCS3 in neutrophil and
macrophage lineages (LysM-creSocs3fl/fl).Asshown inFigure1C,
LysM-cre Socs3fl/flBMMf lacked SOCS3 expression upon infec-
tion. Similarly, while basal levels of SOCS3 transcripts were
present in wild-type BMMf, infection or IL-6 simulation led to
a marked increase, but this was not observed using peritoneal
macrophages andBMMf from LysM-cre Socs3fl/flmice,whereas
levelsofSOCS1werenot affected (FigureS1anddatanotshown).
To assess the role of SOCS3 in the response toT. gondii, LysM-
cre Socs3fl/fl and Socs3fl/fl littermate control mice were chal-
lengedwith the avirulent Pru strain.WhileSocs3fl/flmice survived,
LysM-cre Socs3fl/fl mice succumbed by day 10 (Figure 2A). In
Socs3fl/fl control mice, there were few infected cells in the perito-
neal cavity at day 4with little increase byday8 (Figure 2Band2C).
A similar number of infected cells were observed in the peritoneal
cavity of LysMcre Socs3fl/fl at day 4, as compared to Socs3fl/fl
mice; however, therewasasignificant increase inparasiteburden
by day 8, including the presence of free tachyzoites (Figures 2B,
bottom right arrow, and 2C). Additionally, following infection
with Pru-Tomato, there was an elevated percentage of Tomato+
infected cells in the peritoneal cavity in LysM-cre Socs3fl/fl mice
that did not vary by cell type (Figures 2D and 2E). The use of
real-time PCR revealed that the absence of SOCS3 also resulted
in higher parasite burdens in the liver at day 4, which had
increased dramatically by day 8 (Figure 2F). Histological analysis
of tissues from infectedmice showed little inflammation in control
micebut increased areasof necrosis (arrows) and inflammation in
the liver and lungs of LysM-cre Socs3fl/flmice (Figure 2G), consis-
tent with the increased parasite burdens in these mice.
Activation and Recruitment of Monocytes
and Neutrophils
Several studies have established that inflammatory monocytes
and neutrophils are required for acute resistance to T. gondiiicrobe 10, 224–236, September 15, 2011 ª2011 Elsevier Inc. 225
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Figure 1. T. gondii Upregulates SOCS3 in Macrophages
(A–G) Cultures of macrophages infected with T. gondii demonstrate increased SOCS3 mRNA and protein, which is correlated with STAT3 phosphorylation and
decreased IL-12p40 secretion. SOCS3-deficient macrophages show stronger STAT3 phosphorylation and a defect in IL-12 production. (A) 13 106 BMMf from
C57BL/6 mice were infected with RH or Pru at an moi of 5:1 for the indicated time points. RNA was extracted and reverse transcribed into cDNA, and quantitative
real-time PCR was performed using SOCS3-specific primers. Results are relative to b-actin and representative of two experiments. (B, E, and F) Western blot
analysis was performed on lysates of 13 106 BMMf infected at 1:1 with RH, Pru, or stimulated with STAg (50 mg/ml) and the lysates were probed with a SOCS3-
specific antibody (B), or pSTAT3 and total STAT3 (E and F) and compared to b-actin. (C and D) BMMf were infected at 1:1 for 1 hr with RH-Tomato or RH-Cre-
Cherry and then fixed, stained with antibodies to SOCS3 conjugated to Alexa Fluor 488 and DAPI, and transferred to slides for confocal microscopy. Results are
indicative of two independent experiments. (G) 23 105 BMMfwere infected with 5:1 RH or Pru parasites for 1 hr, then stimulated with LPS (100 ng/ml) for 24 hr.
ELISAs were performed on supernatants for IL-12p40. Error bars ± SD. Results are representative of at least two experiments. Asterisks denote statistically
significant values (p < 0.05) compared to wild-type LPS-treated macrophages.
Cell Host & Microbe
SOCS3 and T. gondii(Egan et al., 2008). Phenotypically, inflammatory monocytes are
CD11b+, F480+, Ly6Chi, CD62L+, MHCIIhi, and CCR2+, and they
migrate to sites of infection and contribute to the control of226 Cell Host & Microbe 10, 224–236, September 15, 2011 ª2011 ElT. gondii (Dunay et al., 2010; Mordue and Sibley, 2003). To test
if the enhanced susceptibility of LysM-cre Socs3fl/fl mice was
due to altered recruitment of these populations, flow cytometrysevier Inc.
Figure 2. LysM-cre Socs3fl/fl Mice Succumb Acutely to T. gondii Infection
(A–G) Infection of LysM-cre Socs3fl/fl mice leads to acute mortality associated with increased parasite burden in the peritoneal cavity and liver along with
increased pathology in the liver and lungs. (A) Socs3fl/fl (n = 5) and LysM-cre Socs3fl/fl (n = 5) were infected i.p. with 104 Pru parasites and survival was determined.
Infected mice were also sacrificed on day 8 to determine parasite burden. (B and C) PECs were collected, centrifuged onto slides, and visualized using light
microscopy for the percentage of infected cells. Arrows denote both intracellular and extracellular tachyzoites, although only cells with intracellular parasites, as
determined by microscopy, were considered infected. (D and E) Socs3fl/fl (n = 5) and LysM-cre Socs3fl/fl (n = 5) were infected i.p. with 1 3 106 Pru-Tomato
parasites and PECs were isolated at day 4 postinfection. The total number of live Pru-Tomato+ cells was counted using flow cytometry and gated on Tomato+
events from the PE channel. (E) From the Pru-Tomato+ cells, the percentage of positive cells that weremonocytes (CD11b+, F4/80+, Ly6C+), neutrophils (CD11b+,
F4/80-, Ly6Clow, GR1+), T cells (CD3+ and CD4+ or CD8+), and NK cells (CD3-, NK1.1+) were evaluated and depicted. (F) DNA was extracted from liver tissue of
infected (day 8) mice (n = 5) and analyzed by real-time PCR for parasite DNA. (G) Livers and lungs of infected (day 8) mice were fixed, sectioned, and imaged using
confocal microscopy. Arrows denote regions of increased pathology. Error bars ± SD. Images and results are representative of two independent experiments.
Statistical values were determined by Student’s t tests.
Cell Host & Microbe
SOCS3 and T. gondiiwas performed on peritoneal cells from infected mice. While the
overall number of peritoneal cells was similar between Socs3fl/fl
control and LysM-cre Socs3fl/fl mice at day 4, there was a signif-
icant increase in recruited cells in LysM-cre Socs3fl/flmice at dayCell Host & M8 (p < 0.05) (Figure 3A). Evaluation of CD11b+ cells in the perito-
neal cavity of uninfected control and LysM-cre Socs3fl/fl mice
revealed that the majority of these cells were resident macro-
phages (F4/80hi, Ly6Cneg) and that the loss of SOCS3 did noticrobe 10, 224–236, September 15, 2011 ª2011 Elsevier Inc. 227
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Figure 3. Inflammatory Monocytes and Neutrophils from LysM-cre Socs3fl/fl Mice Are Deficient in IL-12 Production Following Infection
(A–I) LysM-cre Socs3fl/flmice show impaired IL-12 production from neutrophil and inflammatory monocyte populations recruited to the peritoneal cavity following
infection. (A) Socs3fl/fl (n = 5) and LysM-cre Socs3fl/fl (n = 5) were infected i.p. with 104 Pru parasites and sacrificed at days 4 and 8 postinfection, and the total
number of cells in the peritoneal cavity was quantified alongwith 2 naivemice per group. (B andC) Live, singlet, CD19, CD3, CD11b+ cells were analyzed for the
surface markers Ly6C and F4/80 to identify inflammatory monocytes (F4/80hi, Ly6Chi) and neutrophils (F4/80low, GR1+, Ly6Clow) and quantified. (D–G) Monocyte
and neutrophil populations were stained for the surface markers of activation MHCClass II, CD62L, CD80, and CD86 and compared for the overall expression by
mean fluorescence intensity (MFI). (H and I) To determine IL-12 production from these cell types, intracellular cytokine staining was performed by incubating 13
106 PECs with BFA and Golgi Stop for 5 hr, staining with surface markers for monocytes and neutrophils, fixing with paraformaldehyde, staining for intracellular
IL-12p40, and analyzing by flow cytometry. MFI was calculated and is depicted in red. (I) The percentage of IL-12p40+ inflammatory monocytes and neutrophils
are shown. One-way ANOVA followed by Student’s t test was used to determine statistical significance. Error bars ± SD. Results are representative of two
independent experiments.
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SOCS3 and T. gondiialter the size of this population (Figure 3B, left panel, and data not
shown). Upon infection, there was recruitment of neutrophils
(CD11b+, Ly6Clow, F4/80low, GR1hi) and inflammatory mono-
cytes (CD11b+, F4/80hi, Ly6Chi) (Figure 3B, top right quadrant)
to the peritoneal cavity by day 4, but no significant difference228 Cell Host & Microbe 10, 224–236, September 15, 2011 ª2011 Elin number was observed between control and LysM-cre
Socs3fl/fl mice (Figures 3B and 3C). Moreover, no significant
difference in expression of CD62L, MHCII, CD80, and CD86
was observed between neutrophils or inflammatory monocytes
from these mice (Figures 3D–3G). To assess functionality, thesevier Inc.
40.8 
6.77 IF
N
-γ
 1.1KN 8DC 4DC
BA
CD4 CD8 NK cells
0
2.0x10 5
4.0x10 5
6.0x10 5
8.0x10 5
Ce
lls
 
(P
er
ito
ne
um
)
CD
62
L
CD44
%
 o
f  
CD
4+
T 
ce
lls
C
F
Media STAg
0
10
20
30
40
Sp
le
no
cy
te
IL
-1
2p
40
 (n
g/m
L)
G
Day 4 Post-infection
Media CD3 STAg
0
1
2
3
4
5
Sp
le
no
cy
te
IF
N
-γ
 
(n
g/m
L)
24.8 
5.33 
19.9 
9.76 
D
E
20
40
60
0
Naive Activated
%
 IF
N-
γ+
 
*p<0.05
*p<0.05
p=0.06
59.0
24.7
0.93 24.1
43.4
1.10
31.4
*p<0.05
20
0
40
10
30
CD4 CD8 NK cells
LysM-cre Socs3
fl/fl
Socs3
fl/fl
LysM-cre Socs3
fl/fl Socs3
fl/fl
LysM-cre Socs3
fl/fl
Socs3
fl/fl
LysM-cre Socs3
fl/fl
Socs3
fl/fl
Socs3
fl/fl
LysM-cre 
Socs3
fl/fl
LysM-cre Socs3
fl/fl
Socs3
fl/fl
LysM-cre Socs3
fl/fl
Socs3
fl/fl
15.5
Figure 4. LysM-cre Socs3fl/fl Mice Recruit T and NK Cells with Impaired IFN-g Production
(A–G) T and NK cells traffic to the peritoneal cavity in appropriate numbers by day 4 following infection of LysM-cre Socs3fl/fl mice, yet exhibit a less activated
phenotype with decreased IFN-g production. Socs3fl/fl (n = 5) and LysM-cre Socs3fl/fl (n = 5) were infected i.p. with 104 Pru parasites and sacrificed at days 4 and 8
postinfection. (A) The total number of NK cells (B220, CD3, NK1.1+), CD4+ (B220, CD3+, CD4+), and CD8+ (B220, CD3+, CD8+) T cells were determined by flow
cytometry. (AandB)CD4+Tcellsweremeasured for the surfacemarkersCD62LandCD44and (C)quantified for thenumberofactivated (CD44hi,CD62Llow) andnaive
(CD44low,CD62Lhi) cells permouse. (D,E) For intracellular cytokine staining,PECswere incubatedwithBFA,Golgi Stop,PMA, and ionomycin for 3 hr andanalyzed for
IFN-gproduction following surface staining for NKcells, andCD4+ andCD8+T cells. (F andG)Weplated13 106 splenocytes fromextracted spleensof infectedmice
and stimulated them with media alone or 50 mg/ml STAg. Concentrations of IL-12p40 and IFN-g were measured by ELISA following 24 hr of stimulation. One-way
ANOVA followed by Student’s t test was used to determine statistical significance. Error bars ±SD. Results are representative of two independent experiments.
Cell Host & Microbe
SOCS3 and T. gondiiability of the monocytes and neutrophils to produce IL-12p40
during infection was measured. Critically, there was a significant
reduction in the percentage of IL-12p40+ inflammatory mono-
cytes and neutrophils from LysM-cre Socs3fl/fl mice at day 4
postinfection (Figures 3H and 3I). Together, these findings indi-
cate that the inability of LysM-cre Socs3fl/fl mice to control para-
site replication is not a consequence of a failure to recruit acti-
vated neutrophil or inflammatory monocyte populations, but
correlates with the reduced production of IL-12 of these cells.
LysM-cre Socs3fl/fl Mice Have Impaired NK and T Cell
Responses
Since IL-12 is critical for NK and T cell-mediated resistance to
T. gondii, these populations were examined to determine if theCell Host & Mloss of SOCS3 in macrophages and neutrophils affected
lymphocyte populations and their ability to produce IFN-g. At
day 4, similar numbers of CD4+, CD8+, and NK1.1+ cells were
observed in Socs3fl/fl control and LysM-cre Socs3fl/fl mice sug-
gesting that the loss of SOCS3 in macrophages and neutrophils
did not impair recruitment of these populations to the site of
infection (Figure 4A). Although there was no observable differ-
ence in the population of naive CD4+ T cells in LysM-cre Socs3fl/fl
mice, there was a statistically significant decrease in activated
CD62Llow, CD44hi CD4+ T cells (Figures 4B and 4C). Further-
more, CD4+ T and NK cells from LysM-cre Socs3fl/fl mice were
significantly impaired in their ability to produce IFN-g at day 4,
as compared to control mice with CD8+ T cells demonstrating
the same trend, though not statistically significantly (Figuresicrobe 10, 224–236, September 15, 2011 ª2011 Elsevier Inc. 229
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Figure 5. Infected LysM-cre Socs3fl/fl Mice Show
Impaired IL-12 Production in the Peritoneal Cavity
at Day 4
(A and B) Peritoneal lavage fluid from infected LysM-cre
Socs3fl/fl mice contains a lower concentration of IL-12p40
at day 4, which corresponds to a similar trend in sera ob-
tained from blood. Although IFN-g production appears
normal at day 4, a diminished IFN-g response was ob-
served at day 8 in the peritoneal lavage fluid. Fluid from
intraperitoneal lavage of PECs and serum of infected mice
at days 4 and 8 were collected and analyzed by ELISA for
IL-12p40 and IFN-g. PEC fluid results are presented as ng/
peritoneum which is calculated by multiplying the ELISA
concentration result (ng/ml) by theml quantity of peritoneal
lavage fluid (PBS) recovered following centrifugation. One-
way ANOVA followed by Student’s t test was used to
determine statistical significance. Error bars ± SD. Results
are representative of two independent experiments.
Cell Host & Microbe
SOCS3 and T. gondii4D and 4E). Additionally, no defect in IL-17 production of the
number of IL-17+ CD4+ cells in LysM-cre Socs3fl/fl mice was
observed (Figure S3 and data not shown). To further evaluate
the ability of LysM-cre Socs3fl/fl T cells to produce IFN-g, splenic
recall assays were performed. Surprisingly, after 24 hr of incuba-
tion with media alone, aCD3, or STAg, Socs3fl/fl control and
LysM-cre Socs3fl/fl splenocytes from day 4 infected mice pro-
duced comparable IL-12p40 and IFN-g (Figures 4F and 4G).
However, impaired production of secreted IL-12p40 was ob-
served in the peritoneal lavage fluid at day 4, and a similar trend
was observed in the sera (Figures 5A and 5B). It is noteworthy
that by day 8 postinfection the levels of IL-12p40 detected in
the peritoneum were restored, but that this correlated with the
large increase in parasite burdens (Figure 5B). As the protective
effects of IL-12 are most critical during the first 2–3 days of infec-
tion (Khan et al., 1994), the elevated concentrations observed at
day 8 are not sufficient to confer protection. Similar production of
IFN-g protein was observed at days 4 and 8 postinfection in the
serum and peritoneal lavage fluid, suggesting that any defect in
the production of IL-12 by monocytes and neutrophils may only
affect the earliest production of IFN-g. Together, these findings
demonstrate that the reduced ability of the LysM-cre Socs3fl/fl
mice to control growth of T. gondii is associated with an early
defect in the ability to produce IL-12.
Effect of SOCS3 Deletion on Macrophage Function
One possible explanation for the increased susceptibility of
LysM-cre Socs3fl/fl mice was that SOCS3-deficient macro-
phages were unable to respond to IFN-g to control T. gondii.
To test whether SOCS3-deficient macrophages could respond
appropriately to IFN-g in vitro, BMMf from Socs3fl/fl and LysM-
cre Socs3fl/fl mice were incubated with TNF-a and increasing
concentrations of IFN-g overnight and then infected with Pru
for 24 hr. Stimulated Socs3fl/fl control and LysM-cre Socs3fl/fl
macrophages limited parasite replication in a concentration-
dependent manner (Figure 6A). To determine if IFN-g signaling
was impaired in SOCS3-deficient macrophages, cells were incu-
bated with IFN-g, and the phosphorylation of STAT1 and STAT3230 Cell Host & Microbe 10, 224–236, September 15, 2011 ª2011 Elwas measured. Unlike control macrophages, SOCS3-deficient
macrophages had abbreviated responses to IFN-g, showing
less phosphorylated STAT1 at later time points (Figure 6B). Addi-
tionally, controlmacrophages showed an increase in total STAT1
at 20 hr that was less pronounced in SOCS3-deficient cells. This
observation did not correlate with a reduced ability of the LysM-
cre Socs3fl/fl macrophages to produce nitric oxide (NO), sug-
gesting that this altered STAT1 signaling pattern did not affect
microbicidal activity (Figure 6C). Furthermore, IRGs are critical
to resistance to T. gondii, and when their expression was
measured in wild-type and SOCS3 knockout BMMf stimulated
with IFN-g, similar levels of IRGM3, IRM1, and IRGA6 were de-
tected (Figure 6D). Thus, deletion of SOCS3 appears to have little
impact on the ability of IFN-g to activate antimicrobial responses.
It was previously reported that deletion of SOCS3 frommacro-
phages converted IL-6 signals into anti-inflammatory IL-10-like
signals due to enhanced STAT3 activation (El Kasmi et al., 2006;
Yasukawaet al., 2003). Indeed, IL-6 inducedsustainedphosphor-
ylation of STAT1 and STAT3 in LysM-cre Socs3fl/fl macrophages
as compared toSocs3fl/flmacrophages, yet demonstrated similar
kinetics of activation of theMAP kinase ERK, suggesting that only
STAT signaling is altered in these macrophages (Croker et al.,
2003) (Figures 6E and S2). LysM-cre Socs3fl/fl macrophages
also demonstrated impaired IL-12p40 production in response to
IFN-g and LPS and both Socs3fl/fl and LysM-cre Socs3fl/flmacro-
phages were sensitive to increasing concentrations of IL-6 (Fig-
ure 6F). Addition of neutralizing antibodies to IL-6 restored IL-
12p40 production from LysM-cre Socs3fl/fl macrophages and
increased its production over stimulation alone (Figure 6G), indi-
cating that endogenous IL-6 is an antagonist of IL-12 production
in these cultures. A similar effect of IL-6 on TNF-a productionwas
observed after 48 hr of culture, while IL-6 had no effect on nitric
oxide production (Figure 6H and data not shown).
Anti-IL-6 or IL-12 Treatment Restores Resistance
to T. gondii
The data described above indicate that, in the absence of
SOCS3, IL-6 becomes a potent antagonist of IL-12 production.sevier Inc.
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Figure 6. IL-6 Blocks IL-12p40 Production from Stimulated LysM-cre Socs3fl/fl Macrophages
(A–H) SOCS3-defiicent macrophages do not display impaired microbicidal activity, nitrite production, or IRG expression despite altered IFN-g-mediated
phosphorylation of STAT1. However, IL-12p40 and TNF-a production by SOCS3-deficient macrophages is inhibited by endogenously-produced IL-6 in these
cultures, and this effect can be reversed through the addition of neutralizing antibodies to IL-6. (A) We plated and infected 5 3 105 BMMf with Pru (moi 1:1) for
24 hr following overnight stimulation with TNF-a (10 ng/ml) with increasing concentrations of IFN-g (10-fold dilutions, beginning at 100 units/ml). We centrifuged
2.53 105macrophages onto coverslips for counts of infected cells. (B and D)We treated 13 106 BMMfwith IFN-g (100 units/ml) for the indicated time points and
analyzed by western blot for pSTAT1, IRGM1, IRGM2, IRGM3, IRGD, IRGA6, and IRGB6. (C) Supernatants from (A) were measured for nitrite (nitric oxide)
production following the Griess reaction protocol. (E) Similar to (B), macrophages were stimulated with IL-6 (100 ng/ml) for the indicated time points and analyzed
for pSTAT3 and pSTAT1. (F) The ability of IL-6 to inhibit IL-12p40 production was evaluated by stimulating 2 3 105 BMMf with IFN-g and LPS (10 units/ml and
10 ng/ml, respectively) with or without increasing concentrations of IL-6 (10-fold dilutions, beginning at 100 ng/ml) for 24 hr and analyzing by ELISA. (G and H) 23
105 BMMf were given IFN-g and LPS with or without a-IL-6 and analyzed for IL-12p40 and TNF-a production. Error bars ± SD. Statistics were performed using
Student’s t tests, and results are representative of two independent experiments.
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SOCS3 and T. gondiiDuring acute infection, IL-6 is upregulated in both Socs3fl/fl
control and LysM-cre Socs3fl/fl mice and is detected in the peri-
toneal cavity and sera by day 4 (data not shown). To test whether
endogenous IL-6 contributed to the observed susceptibility of
LysM-cre Socs3fl/fl mice, Socs3fl/fl and LysM-cre Socs3fl/fl mice
were treated with neutralizing antibodies to IL-6. Socs3fl/fl and
LysM-cre Socs3fl/fl mice showed an increase in IL-6 production
at day 8 postinfection; however, the LysM-cre Socs3fl/fl mice
produced higher levels of IL-6 (Figure 7A). Furthermore, neutral-
ization of IL-6 markedly reduced the available IL-6 in Socs3fl/fl
and LysM-cre Socs3fl/fl mice (Figure 7A). When these mice
were evaluated for survival, control mice given the a-IL-6 treat-
ment survived up to 40 days after challenge (Figure 7B), whereasCell Host & MLysM-cre Socs3fl/flmice treatedwith rat IgG succumbed acutely.
However, when these mice were treated with a-IL-6, 80% of the
mice survived acute challenge and progressed into the chronic
phase of this infection (Figure 7B). Indeed, treatment with
a-IL-6 resulted in a marked reduction in the number of infected
cells in the peritoneal cavity at day 8 in Socs3fl/fl and LysM-cre
Socs3fl/fl mice (Figure 7C). Similarly, IL-17, IL-10, IL-12p40,
and IFN-g levels were reduced in the peritoneal cavity (Figure 7D)
and serum (data not shown) of Socs3fl/fl and LysM-cre Socs3fl/fl
mice. The reduced cytokine production observed following
a-IL-6 treatment is likely the result of an overall decrease in
T cell and monocyte recruitment to the peritoneal cavity
associated with lower parasite burdens. Given the reducedicrobe 10, 224–236, September 15, 2011 ª2011 Elsevier Inc. 231
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Figure 7. Administration of IL-12 or Neutralizing Antibodies to IL-6 Reduces Parasite Burdens andOverall Inflammation in LysM-cre Socs3fl/fl
Mice
(A–J) In vivo neutralization of IL-6 reduces acute mortality of infected LysM-cre Socs3fl/fl mice, which correlates with reduced parasite burdens and indicators of
Th1 inflammation. (A–D) We administered 200 mg/mouse of rat IgG or a-IL-6 i.p. to 5 mice per group on the day preceding infection as well as 2 days postinfection
with 104 Pru parasites. (A) Mice were sacrificed at day 8 postinfection and IL-6 was measured in the peritoneum to confirm neutralization. (B) Survival of infected
mice was evaluated on infected mice (five per group) and carried out to 40 days. (C) The percentage of infected cells in the peritoneal cavity was measured
similarly to the percentage in Figure 2C and described in Experimental Procedures. (D) IL-12p40 and IFN-g production was also measured in the peritoneum as
described in Figure 5 and Experimental Procedures. (E) Thioglycollate-elicited macrophages were used to determine if a-IL-6 treatments could restore IL-12
production from LysM-cre Socs3fl/fl macrophages. IL-12p40 was measured by ELISA from 24 hr cultures of 2.5 3 105 thioglycollate-elicited macrophages
isolated from the peritoneal cavity on day 4 following the antibody regimen described above. Experiments were repeated twice. To test whether addition of IL-12
could rescue lethality in LysM-cre Socs3fl/flmice, 200 ng of IL-12 was injected on days 0–3 postinfection with 104 Pru for mice sacrificed on day 4 and days 0–5 for
mice sacrificed on day 7. (F) Mice were infected and monitored for signs of mortality and (F) depicts a modified survival curve for control and LysM-cre Socs3fl/fl
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SOCS3 and T. gondiiinflammation following a-IL-6 treatment, it is difficult to deter-
mine if this treatment restored IL-12 production in this model.
Therefore, to determine if neutralizing IL-6 in vivo alters IL-12
responses, control and LysM-cre Socs3fl/fl mice were injected
with thioglycollate and treated with IgG or a-IL-6. As predicted,
thioglycollate-elicited macrophages from LysM-cre Socs3fl/fl
mice demonstrated impaired IL-12p40 production but this effect
was reversed when these mice were treated with neutralizing
antibodies to IL-6 (Figure 7E). Overall, these data suggest that
IL-6 is an inhibitor of IL-12 production during toxoplasmosis
and that LysM-cre Socs3fl/fl mice are hypersensitive to these
effects.
To determine if LysM-cre Socs3fl/fl mice could survive chal-
lenge when provided with exogenous IL-12, mice were infected
and given 200 ng of IL-12 i.p. for 5 days. By day 7, control LysM-
cre Socs3fl/fl mice were moribund associated with an 8% loss in
body weight, while IL-12 treated LysM-cre Socs3fl/fl mice ap-
peared healthy and lost significantly less weight (4%, which
was comparable to infected wild-type controls). Further analysis
on days 4 and 7 showed that IL-12 treatment resulted in
a dramatic reduction in parasite loads in the peritoneum and liver
(Figures 7F and 7G) to levels comparable to wild-type controls
(data not shown). This was accompanied by a reduction in the
overall numbers of neutrophils, monocytes, T cells, and NK cells
at day 4 (Figures 7H and 7I and data not shown) and reduced
levels of proinflammatory cytokines (Figure S4). Thus, treatment
of infected LysM-cre Socs3fl/fl mice with IL-12 is sufficient to
overcome the inhibitory effects mediated by IL-6.
DISCUSSION
Several reports have highlighted the ability of T. gondii to induce
the phosphorylation of STAT3 associated with the ability to
suppress cytokine production (Butcher et al., 2005b; Saeij
et al., 2007). This phenomenon has been linked to the activity
of a parasite kinase, ROP16, that is injected into host cells where
it can directly phosphorylate STAT3 (Saeij et al., 2007; Yama-
moto et al., 2009). How these events limit cytokine production
is unclear, but the observation that T. gondii also upregulates
SOCS3, a well-characterized target of STAT3 linked to inhibition
of cytokine signaling, suggested a possible mechanism. How-
ever, in vitro studies revealed that SOCS3 was not required for
T. gondii to limit macrophage cytokine production. Rather, the
use of the LysM-cre Socs3fl/fl mice revealed that SOCS3 was
essential for appropriate innate responses mediated by neutro-
phils and monocytes/macrophages, required for the control of
T. gondii.
While little is known about the role of SOCS3 in resistance to
infection, the ability of this protein to limit cytokine signaling
through the receptor gp130 has been described in detail (Murray,
2007). Thus, while cytokines such as IL-6 and IL-10 can activatemice given PBS or IL-12. Day 7 was chosen as the day for sacrifice, as only untre
(i.e., hind-limb paralysis, malaise, ocular opacity, etc.). (G) The peritoneum of mice
as previously described. Results are indicative of two independent experiments
isolated as previously described. Real-time analysis was performed on parasite D
points and measured against a standard curve. (I and J) Peritoneal cells from day
flow cytometry for the presence of T cells, NK cells, monocytes, and neutrophils a
and results are representative of two independent experiments.
Cell Host & MSTAT3 and upregulate SOCS3, this inhibitory protein binds
directly to the gp130 subunit of the IL-6 receptor complex but
not the IL-10R, and so SOCS3 acts to inhibit IL-6 but not IL-10
signaling (El Kasmi et al., 2006; Yasukawa et al., 2003). However,
our data show that the absence of SOCS3 resulted in enhanced
T. gondii-induced STAT3 signaling. This suggests that either the
ROP16 secreted by T. gondii following infection associates with
the gp130 subunit and is inhibited by SOCS3 (similarly to an IL-6
stimulus) or that SOCS3 has an additional mechanism to limit
phosphorylation of STAT3. Thus, the ROP16-mediated mecha-
nism by which T. gondii activates STAT3 may be more complex
than just direct phosphorylation of this substrate.
The significance of the inhibitory action of IL-6 has been docu-
mented in reports that, in the absence of SOCS3, IL-6 induces
a sustained STAT3 signal similar to that of IL-10 and becomes
a potent inhibitor of macrophage production of TNF-a and
IL-12 (Yasukawa et al., 2003). Indeed, addition of a-IL-6 to
cultures of SOCS3-deficient macrophages stimulated with
IFN-g/LPS resulted in enhanced IL-12p40 production. Consis-
tent with this observation, the neutralization of IL-6 in the
LysM-cre Socs3fl/fl mice allowed these mice to control the acute
challenge with T. gondii and develop the protective responses
required for long-term resistance to this infection. Thus, it
appears that in the absence of SOCS3, the IL-6 produced during
infection has a profound inhibitory effect on the innate response
similar to the observation that LysM-cre Socs3fl/fl mice have
increased resistance to sepsis (Yasukawa et al., 2003).
One of the themes that emerged from these studies was that
IL-6, even in wild-type cells, has significant but specific inhibitory
effects. For example, whenwild-typemacrophages were treated
with IL-6, their ability to produce IL-12p40 was selectively
inhibited while effector molecules such as nitric oxide were unaf-
fected. Additionally, when control mice were treated with neu-
tralizing antibodies to IL-6, their ability to control early parasite
replication was enhanced, suggesting that IL-6 is a natural inhib-
itor of the innate mechanisms that contribute to early control of
T. gondii. IL-6, similarly to IL-10, can antagonize the ability of
IFN-g-activated macrophages to limit the replication of several
intracellular organisms (Beaman et al., 1994; Bermudez et al.,
1992; Hatzigeorgiou et al., 1993). Based on these in vitro studies,
the ability of IL-6 to antagonize antimicrobial activities might
have explained why LysM-cre Socs3fl/fl mice were unable to
control parasite burden. However, the observation that the rela-
tive percentage of infected macrophages and neutrophils is
identical between control and LysM-cre Socs3fl/fl mice indicates
that the absence of SOCS3 does not result in a cell-intrinsic
defect in the ability to control T. gondii. Thus, SOCS3-deficient
macrophages can control parasite replication adequately when
provided appropriate signals, and so the enhanced susceptibility
observed in the absence of SOCS3 is most consistent with an
early defect in the innate response.ated LysM-cre Socs3fl/fl mice exhibited behavior indicating imminent mortality
was washed and cells were centrifuged onto slides for counts of infected cells
with at least three mice per group. (H) Liver sections were taken and DNA was
NA in liver sections from control and LysM-cre Socs3fl/fl mice at the given time
4 LysM-cre Socs3fl/flmice, either treated with IL-12 or PBS, were measured by
nd depicted. Error bars ± SD. Statistics were performed using Student’s t tests,
icrobe 10, 224–236, September 15, 2011 ª2011 Elsevier Inc. 233
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SOCS3 and T. gondiiWhile this study has focused on the contribution of IL-6 to the
regulation of inflammatory responses during toxoplasmosis, this
cytokine is also important in many other settings where patho-
gens appear to benefit from the inhibitory effects of IL-6. For
example, IL-6 promotes growth of Leishmania, T. gondii, and
Mycobacterium species (Beaman et al., 1994; Bermudez et al.,
1992; Hatzigeorgiou et al., 1993; Murray, 2008) and has been
associated with enhanced lytic replication of human herpes
virus-8 (HHV-8) and exacerbated disease in patients coinfected
with HIV (Uldrick et al., 2010). Moreover, HHV-8 encodes a viral
IL-6 gene that has been shown to impair neutrophil recruitment
and promote viral growth in vitro (Fielding et al., 2005; Sun
et al., 1998). From a host perspective, resistance to many path-
ogens is characterized by the need to balance the development
of a strong cell-mediated immune response with the ability to
limit collateral damage caused by the immune system. Indeed,
there are many examples of inhibitory pathways that prevent
infection-induced immune hyperactivity and the SOCS proteins
also limit signals that promote excessive inflammation. SOCS1
is best described as a regulator of Type I and II IFN-mediated
phosphorylation of STAT1 (Fenner et al., 2006; Gingras et al.,
2004) and has been shown to diminish IFN-g responsiveness
to T. gondii, L. major, and hepatitis C virus (Alexander et al.,
1999; Vlotides et al., 2004; Zimmermann et al., 2006). However,
while SOCS3 can regulate IFN responses, its main role during
toxoplasmosis, and possibly other intracellular pathogens, is to
limit the anti-inflammatory actions of IL-6. Thus, SOCS3 differen-
tiates itself from other SOCS family members, and its signaling
pathway can be considered among those that promote appro-
priate and effective Th1 immunity.
EXPERIMENTAL PROCEDURES
Mice and Infections
LysM-cre Socs3fl/flmice were generated as previously described (Croker et al.,
2003). C57BL/6 mice were obtained from Taconic Farms Inc (Germantown,
NY). C57BL/6, Socs3fl/fl, and LysM-cre Socs3fl/flmice were bred in the Univer-
sity Laboratory Animal Resources facilities at the University of Pennsylvania.
All procedures were performed in accordance with the guidelines of the
University of Pennsylvania Institutional Animal Care and Use Committee. RH
and Prugniaud (Pru) parasites were grown in human foreskin fibroblast (HFF)
monolayers cultured with D10 media (DMEM, 25% M199 Supplement, 10%
fetal bovine serum, 0.5% penicillin/streptomycin [10,000 mg/ml], 0.5% genta-
mycin [50 mg/ml]) as previously described (Wille et al., 2004). RH-Cre-Cherry
parasites were obtained from John Boothroyd and passaged as described
(Koshy et al., 2010). Injections of 200 mg of a-IL-6 (BioXCell, West Lebanon,
NH) or rat IgG (Sigma, St. Louis) were administered i.p. at days1 and 2 post-
infection. Injections of 200 ng of IL-12 (PeproTech, Rocky Hill, NJ) were admin-
istered on the day of the infection as well as for the first 3 or 5 days prior to
sacrificing the mice on day 4 or 7 respectively. Thioglycollate injections were
performed i.p. with 0.5 ml of 4% Brewer’s thioglycollate medium (Sigma)
and peritoneal exudates cells (PECs) were harvested on day 4 as described
(Wille et al., 2004).We then plated 2.5 3 105 thioglycollate-elicited macro-
phages for 24 hr in 200 ml total volume, and supernatants were used for detec-
tion of IL-12p40 production by ELISA.
Immunoblotting
Bonemarrow-derived macrophages (BMMf) were grown in DMEM containing
1% sodium pyruvate, 1% penicillin/streptomycin, 10% FBS, 30% L929 cell
supernatant, and 1% HEPES (Shapira et al., 2005). 1 3 106 BMMf were
cultured in 96-well plates overnight and then infected with 5:1 Pru. Lysates
were prepared using TNT buffer (0.1 M Tris-HCl [pH 7.5], 0.15 M NaCl, and
0.05% Tween 20) combined with complete protease inhibitors (Roche, Man-234 Cell Host & Microbe 10, 224–236, September 15, 2011 ª2011 Elnheim, Germany) at 1:100 for 20min on ice and then stored at20C. Samples
were electrophoresed and transferred to Immobilon-P membrane (Millipore,
Bedford, MA) and blocked for 1 hr in 5% nonfat dry milk and probed overnight
with mouse monoclonal antibodies to SOCS3 (Invitrogen, Carlsbad, CA),
b-actin, pSTAT3, total STAT3, pSTAT1, total STAT1, pERK, and total ERK
(Cell Signaling, Danvers, MA) and IRGM1, IRGM2, IRGM3, IRGD, IRGA6, or
IRGB6 (Santa Cruz Biotechnology, Santa Cruz, CA). Blots were washed in
TBS-Tween and probedwith a-mouse or a-rabbit secondary antibodies conju-
gated to horseradish peroxidase (Jackson ImmunoResearch,West Grove, PA)
at 1:10,000 for 1 hr at room temperature. Blots were washed and developed
with enhanced chemiluminescence and exposed to film.
Confocal Immunofluorescence Microscopy
We isolated and cultured 5 3 105 BMMf in 96-well plates and infected at
a multiplicity of infection (moi) of 1:1 RH-Tomato or RH-Cre-Cherry parasites.
Cells were blocked in 5% BSA, fixed with 2% paraformaldehyde, incubated
with monoclonal a-SOCS3 (Invitrogen) overnight, washed, and detected by
incubation with biotinylated anti-mouse antibodies and streptavidin conju-
gated to Alexa Fluor 488 (Invitrogen). Cells were then washed and visualized
using theNikon Eclipse E600microscope (Melville, NY) equippedwith a Photo-
metrics CoolSNAP EZCCD camera (Tucson, AZ). Results are representative of
two independent experiments.
RNA Isolation and Quantitative Real Time PCR
RNA was isolated using the RNeasy kit (QIAGEN) according to the manufac-
turer’s instructions and reverse transcribed into cDNA using SuperScript II
(Invitrogen) using standard protocols. Quantitative PCR was performed with
customized primer sets for Socs3 (Forward 50-ACCAGCGCCACTTCTTC
ACG-30, Reverse 50-GTGGAGCATCATACTGATCC-30) and Socs1 (Forward
50-ACTTCTGGCTGGAGACCTCA-30, Reverse 50-CCCAGACACAAGCTGCT
ACA-30) using Power SYBR Green reagents and an AB 7500 Fast Real-Time
PCR thermal cycler (Applied Biosystems, Warrington, UK). The values for
Socs3 were normalized to b-actin (QIAGEN, Germantown, MD). Parasite
DNA levels were measured by real-time PCR of the T. gondii B1 gene, using
DNA isolated from tissue samples using the High Pure PCR Template Purifica-
tion Kit (Roche) and SYBR Green PCR Master Mix (Applied Biosystems) in an
AB 7500 Fast Real-Time PCR machine (Applied Biosystems) using published
conditions (Wilson et al., 2005).
Cytokine and Flow Cytometric Analysis
Splenocytes were washed and resuspended in complete RPMI 1640
(Invitrogen) containing 10% FBS (Serum Source International), 1% penicillin/
streptomycin (Invitrogen), 1 mM sodium pyruvate (Mediatech, Manassas,
VA), 2 mM L-glutamine (Mediatech), 0.1% 2-mercaptoethanol (Invitrogen)
before being plated at 1 3 106 cells per well in a volume of 200 ml in 96-well
plates (Costar, Corning, NY). Cells were stimulated with or without soluble
Toxoplasma antigen (STAg) at 50 mg/ml, or a-CD3 at 1 mg/ml (eBioscience)
for 24 hr at 37C in 5% CO2. Peritoneal cells were isolated as previously
described (Wilson et al., 2005) and cell-free peritoneal wash fluid was used
for cytokine analysis. Concentrations were normalized to the amount of perito-
neal fluid recovered from each mouse. Blood was collected via cardiac punc-
ture. Concentrations of IFN-g, IL-12p40, IL-17, IL-10, and IL-6 were deter-
mined by ELISA using antibodies from eBioscience (San Diego, CA). Freshly
isolated PECs from infected mice were incubated with Fc block (0.1 mg/ml
24G2 antibody) for 15 min prior to surface staining with Ly6C-PerCP 5.5
(HK1.4), CD11b-FITC (M1/70), F4/80-eFluor 780 (BM8), GR1-PECy7 (RB6-
8C5), CD86-APC (16-10A1), CD80-PE (GL1), NK1.1-PE (PK136), CD4-eFluor
780 (RM4-5), CD8-PerCP 5.5 (53-6.7), CD19-PECy7 (eBio1D3 (1D3)),
CD11c-APC (N418), CD62L-APC (MEL-14), and CD44-PE (IM7) (eBioscience,
San Diego, CA), MHC Class II I-A/I-E (Biolegend, M5/114.15.2), CD3ε-Pacific
Blue (500A2), and CD19-Pacific Blue (1D3) (BD Biosciences). For intracellular
cytokine staining, 13 106 PECs were plated in RPMI 1640 and stimulated with
PMA (50 ng/ml) and ionomycin (500 ng/ml) in the presence of brefeldin A
(10 mg/ml) (Sigma) for 4 hr at 37C with 5% CO2 unless otherwise noted. The
cells were fixed with 2% paraformaldehyde following surface stain (Electron
Microscopy Science, Hatfield, PA) for 10 min. For intracellular staining, the
cells were permeabilized with 0.5% saponin (Sigma, St. Louis) and stained
with anti-IFN-g-APC (XMG1.2) or IL-12p40-APC (17.8) (eBioscience). All flowsevier Inc.
Cell Host & Microbe
SOCS3 and T. gondiicytometry was performed on a FACSCanto using FACSDIVA 6.0 software
(BD Biosciences, San Jose, CA). Analysis was performed using FlowJo soft-
ware (Treestar Inc., Ashland, OR).
In Vitro Killing Assay and Inhibition Assays
We harvested 5 3 105 BMMf, cultured them in 96-well plates, and pretreated
them overnight with media alone or IFN-g (R&D Systems, Minneapolis, MN)
and TNF-a (eBioscience) at indicated concentrations. Cells were then infected
with Pru at 1:1 and incubated overnight. Cells were then centrifuged onto micro-
scope slides and the number of infectedmacrophageswas counted. Nitrite anal-
ysiswasperformedusing theGriessprotocol aspreviouslydescribed (Stuehrand
Nathan, 1989). For parasite cytokine-inhibition assays, 2 3 105 BMMf were
plated and infected with either RH or Pru parasites at an moi of 1:1 for 1 hr prior
to LPS stimulation (100 ng/ml, Sigma) for 24 hr. For IL-6 inhibition assays,
BMMf were stimulated with IFN-g (10 ng/ml) and LPS (10 ng/ml) ± IL-6 at
10-fold increments beginning at 0.001 ng/ml (eBioscience) or a-IL-6 (100 ng/ml,
BioXCell) and IL-12p40 and TNF-a were assayed by ELISAs (eBioscience).
Statistical analysis
Statistical analysis was conducted on normally distributed data with Student’s
t test or one-way ANOVA, and correlations were calculated with Prism soft-
ware (GraphPad Software).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
chom.2011.07.009.
ACKNOWLEDGMENTS
This work was supported by grants to C.A.H. and C.M.G. C.A.H.: State of
Pennsylvania and NIH AI42334. C.M.G.: University of Pennsylvania NIHTG
T32 GM07229.
Received: March 3, 2011
Revised: June 8, 2011
Accepted: July 25, 2011
Published: September 14, 2011
REFERENCES
Alexander, W.S., Starr, R., Fenner, J.E., Scott, C.L., Handman, E., Sprigg,
N.S., Corbin, J.E., Cornish, A.L., Darwiche, R., Owczarek, C.M., et al. (1999).
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the
potentially fatal neonatal actions of this cytokine. Cell 98, 597–608.
Andrade, R.M., Portillo, J.A., Wessendarp, M., and Subauste, C.S. (2005).
CD40 signaling in macrophages induces activity against an intracellular path-
ogen independently of gamma interferon and reactive nitrogen intermediates.
Infect. Immun. 73, 3115–3123.
Beaman, M.H., Hunter, C.A., and Remington, J.S. (1994). Enhancement of
intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-
gamma and TNF-alpha. J. Immunol. 153, 4583–4587.
Bermudez, L.E., Wu, M., Petrofsky, M., and Young, L.S. (1992). Interleukin-6
antagonizes tumor necrosis factor-mediated mycobacteriostatic and myco-
bactericidal activities in macrophages. Infect. Immun. 60, 4245–4252.
Butcher, B.A., Kim, L., Johnson, P.F., and Denkers, E.Y. (2001). Toxoplasma
gondii tachyzoites inhibit proinflammatory cytokine induction in infected
macrophages by preventing nuclear translocation of the transcription factor
NF-kappa B. J. Immunol. 167, 2193–2201.
Butcher, B.A., Greene, R.I., Henry, S.C., Annecharico, K.L., Weinberg, J.B.,
Denkers, E.Y., Sher, A., and Taylor, G.A. (2005a). p47 GTPases regulate
Toxoplasma gondii survival in activated macrophages. Infect. Immun. 73,
3278–3286.
Butcher, B.A., Kim, L., Panopoulos, A.D., Watowich, S.S., Murray, P.J., and
Denkers, E.Y. (2005b). IL-10-independent STAT3 activation by ToxoplasmaCell Host & Mgondii mediates suppression of IL-12 and TNF-alpha in host macrophages.
J. Immunol. 174, 3148–3152.
Croker, B.A., Krebs, D.L., Zhang, J.G., Wormald, S., Willson, T.A., Stanley,
E.G., Robb, L., Greenhalgh, C.J., Fo¨rster, I., Clausen, B.E., et al. (2003).
SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540–545.
Dalpke, A., Heeg, K., Bartz, H., and Baetz, A. (2008). Regulation of innate
immunity by suppressor of cytokine signaling (SOCS) proteins.
Immunobiology 213, 225–235.
Denkers, E.Y., and Gazzinelli, R.T. (1998). Regulation and function of T-cell-
mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev.
11, 569–588.
Dunay, I.R., Fuchs, A., and Sibley, L.D. (2010). Inflammatory monocytes but
not neutrophils are necessary to control infection with Toxoplasma gondii in
mice. Infect. Immun. 78, 1564–1570.
Egan, C.E., Sukhumavasi, W., Bierly, A.L., and Denkers, E.Y. (2008).
Understanding the multiple functions of Gr-1(+) cell subpopulations during
microbial infection. Immunol. Res. 40, 35–48.
El Kasmi, K.C., Holst, J., Coffre,M., Mielke, L., de Pauw, A., Lhocine, N., Smith,
A.M., Rutschman, R., Kaushal, D., Shen, Y., et al. (2006). General nature of the
STAT3-activated anti-inflammatory response. J. Immunol. 177, 7880–7888.
Fenner, J.E., Starr, R., Cornish, A.L., Zhang, J.G., Metcalf, D., Schreiber, R.D.,
Sheehan, K., Hilton, D.J., Alexander, W.S., and Hertzog, P.J. (2006).
Suppressor of cytokine signaling 1 regulates the immune response to infection
by a unique inhibition of type I interferon activity. Nat. Immunol. 7, 33–39.
Fielding, C.A., McLoughlin, R.M., Colmont, C.S., Kovaleva, M., Harris, D.A.,
Rose-John, S., Topley, N., and Jones, S.A. (2005). Viral IL-6 blocks neutrophil
infiltration during acute inflammation. J. Immunol. 175, 4024–4029.
Gingras, S., Parganas, E., de Pauw, A., Ihle, J.N., and Murray, P.J. (2004). Re-
examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the
regulation of toll-like receptor signaling. J. Biol. Chem. 279, 54702–54707.
Hatzigeorgiou, D.E., He, S., Sobel, J., Grabstein, K.H., Hafner, A., and Ho, J.L.
(1993). IL-6 down-modulates the cytokine-enhanced antileishmanial activity in
human macrophages. J. Immunol. 151, 3682–3692.
Khan, I.A., Matsuura, T., and Kasper, L.H. (1994). Interleukin-12 enhances
murine survival against acute toxoplasmosis. Infect. Immun. 62, 1639–1642.
Kim, S.K., Fouts, A.E., and Boothroyd, J.C. (2007). Toxoplasma gondii dysre-
gulates IFN-gamma-inducible gene expression in human fibroblasts: insights
from a genome-wide transcriptional profiling. J. Immunol. 178, 5154–5165.
Koshy, A.A., Fouts, A.E., Lodoen, M.B., Alkan, O., Blau, H.M., and Boothroyd,
J.C. (2010). Toxoplasma secreting Cre recombinase for analysis of host-
parasite interactions. Nat. Methods 7, 307–309.
Kubo, M., Hanada, T., and Yoshimura, A. (2003). Suppressors of cytokine
signaling and immunity. Nat. Immunol. 4, 1169–1176.
Lieberman, L.A., Banica, M., Reiner, S.L., and Hunter, C.A. (2004). STAT1
plays a critical role in the regulation of antimicrobial effector mechanisms,
but not in the development of Th1-type responses during toxoplasmosis.
J. Immunol. 172, 457–463.
Lu¨der, C.G., Walter, W., Beuerle, B., Maeurer, M.J., and Gross, U. (2001).
Toxoplasma gondii down-regulates MHC class II gene expression and antigen
presentation by murine macrophages via interference with nuclear transloca-
tion of STAT1alpha. Eur. J. Immunol. 31, 1475–1484.
Martens, S., Parvanova, I., Zerrahn, J., Griffiths, G., Schell, G., Reichmann, G.,
and Howard, J.C. (2005). Disruption of Toxoplasma gondii parasitophorous
vacuoles by the mouse p47-resistance GTPases. PLoS Pathog. 1, e24.
Mordue, D.G., and Sibley, L.D. (2003). A novel population of Gr-1+-activated
macrophages induced during acute toxoplasmosis. J. Leukoc. Biol. 74,
1015–1025.
Murray, P.J. (2007). The JAK-STAT signaling pathway: input and output inte-
gration. J. Immunol. 178, 2623–2629.
Murray, H.W. (2008). Accelerated control of visceral Leishmania donovani
infection in interleukin-6-deficient mice. Infect. Immun. 76, 4088–4091.icrobe 10, 224–236, September 15, 2011 ª2011 Elsevier Inc. 235
Cell Host & Microbe
SOCS3 and T. gondiiRobben, P.M., Mordue, D.G., Truscott, S.M., Takeda, K., Akira, S., and Sibley,
L.D. (2004). Production of IL-12 by macrophages infected with Toxoplasma
gondii depends on the parasite genotype. J. Immunol. 172, 3686–3694.
Saeij, J.P., Coller, S., Boyle, J.P., Jerome, M.E., White, M.W., and Boothroyd,
J.C. (2007). Toxoplasma co-opts host gene expression by injection of a poly-
morphic kinase homologue. Nature 445, 324–327.
Scharton-Kersten, T.M., Yap, G., Magram, J., and Sher, A. (1997). Inducible ni-
tric oxide is essential for host control of persistent but not acute infection with
the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185, 1261–1273.
Shapira, S., Speirs, K., Gerstein, A., Caamano, J., and Hunter, C.A. (2002).
Suppression of NF-kappaB activation by infection with Toxoplasma gondii.
J. Infect. Dis. 185 (Suppl 1 ), S66–S72.
Shapira, S., Harb, O.S., Margarit, J., Matrajt, M., Han, J., Hoffmann, A.,
Freedman, B., May, M.J., Roos, D.S., and Hunter, C.A. (2005). Initiation and
termination of NF-kappaB signaling by the intracellular protozoan parasite
Toxoplasma gondii. J. Cell Sci. 118, 3501–3508.
Sher, A., Collazzo, C., Scanga, C., Jankovic, D., Yap, G., and Aliberti, J. (2003).
Induction and regulation of IL-12-dependent host resistance to Toxoplasma
gondii. Immunol. Res. 27, 521–528.
Stuehr, D.J., and Nathan, C.F. (1989). Nitric oxide. A macrophage product
responsible for cytostasis and respiratory inhibition in tumor target cells.
J. Exp. Med. 169, 1543–1555.
Sun, R., Lin, S.F., Gradoville, L., Yuan, Y., Zhu, F., and Miller, G. (1998). A viral
gene that activates lytic cycle expression of Kaposi’s sarcoma-associated
herpesvirus. Proc. Natl. Acad. Sci. USA 95, 10866–10871.
Uldrick, T.S., Wang, V., O’Mahony, D., Aleman, K., Wyvill, K.M., Marshall, V.,
Steinberg, S.M., Pittaluga, S., Maric, I., Whitby, D., et al. (2010). An inter-
leukin-6-related systemic inflammatory syndrome in patients co-infected236 Cell Host & Microbe 10, 224–236, September 15, 2011 ª2011 Elwith Kaposi sarcoma-associated herpesvirus and HIV but without
Multicentric Castleman disease. Clin. Infect. Dis. 51, 350–358.
Vlotides, G., So¨rensen, A.S., Kopp, F., Zitzmann, K., Cengic, N., Brand, S.,
Zachoval, R., and Auernhammer, C.J. (2004). SOCS-1 and SOCS-3 inhibit
IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA.
Biochem. Biophys. Res. Commun. 320, 1007–1014.
Wille, U., Nishi, M., Lieberman, L., Wilson, E.H., Roos, D.S., and Hunter, C.A.
(2004). IL-10 is not required to prevent immune hyperactivity during memory
responses to Toxoplasma gondii. Parasite Immunol. 26, 229–236.
Wilson, E.H., Wille-Reece, U., Dzierszinski, F., and Hunter, C.A. (2005). A
critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis.
J. Neuroimmunol. 165, 63–74.
Yamamoto, M., Standley, D.M., Takashima, S., Saiga, H., Okuyama, M.,
Kayama, H., Kubo, E., Ito, H., Takaura, M., Matsuda, T., et al. (2009). A single
polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the
direct and strain-specific activation of Stat3. J. Exp. Med. 206, 2747–2760.
Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada,
T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003). IL-6 induces an anti-
inflammatory response in the absence of SOCS3 in macrophages. Nat.
Immunol. 4, 551–556.
Zhao, Y., Ferguson, D.J., Wilson, D.C., Howard, J.C., Sibley, L.D., and Yap,
G.S. (2009). Virulent Toxoplasma gondii evade immunity-related GTPase-
mediated parasite vacuole disruption within primed macrophages.
J. Immunol. 182, 3775–3781.
Zimmermann, S., Murray, P.J., Heeg, K., and Dalpke, A.H. (2006). Induction of
suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to
immune evasion in macrophages by blocking IFN-gamma signaling.
J. Immunol. 176, 1840–1847.sevier Inc.
